Global Antimicrobials Market Assessment, By Grade [Food Grade, Pharma Grade, Industrial Grade], By Type [Organics, Inorganics], By Applications [Antiviral Protection, Food Packaging, Bacterial Growth Inhibition, Others], By End-user [Homecare Essentials, Agriculture, Cleaners & Detergents, Paper & Pulp, Inks & Adhesives, Pharmaceuticals, Personal Care, Others], By Region, Opportunities and Forecast, 2016-2030F
Global antimicrobials market size was valued at USD 41.82 billion in 2022, which is expected to reach USD 60.4 billion in 2030, with a CAGR of 4.7% for the forecast period between 2023 and 2030.
Home>Industry Reports>Global Antimicrobials Market Assessment, Opportunities and Forecast, 2016-2030F
Global antimicrobials market size was valued at USD 41.82 billion in 2022, expected to reach USD 60.4 billion in 2030, with a CAGR of 4.7% for the forecast period between 2023 and 2030. The discovery of antimicrobials has benefited various sectors progressively with the adopted innovations. The incorporated antimicrobials deliver specific characteristics based on the group they belong to. Specific mechanisms, such as inhibiting protein, cell wall, and nuclei acid synthesis, depolarize the cell membrane and inhibit metabolic pathways in bacteria. Antimicrobial peptides have the potential to impart either antimicrobial or anticancer activities that subsequently disrupt microbial cell membranes by making proper interaction with negatively charged phospholipids. Antimicrobials have extensive involvement in the agri-food sector, which is responsible for imprudent use, and their prominent contribution to resistance can diminish the concerns for health emergencies.
Extensive Application in Daily Essentials Augments Market Growth
Several prominent factors of antimicrobial compounds are responsible for their numerous applications in balancing hygienic-critical environments. Incorporating antimicrobial compounds assists in enhancing the cleanliness and freshness of everyday products by restricting the proliferation of unpleasant mold and mildew. Its essential characteristic is preserving plastic products by inhibiting physical degradation from fungi and bacteria. By minimizing stain and odor-causing bacteria, antimicrobial compounds remain potentially active in imparting laundering properties in fabric care products.
The global home care product market has grown significantly from USD 1,095.63 billion in 2022 to USD 1,155.36 billion in 2023, recognized as a phenomenal rising sector. The frequent investment in innovations to develop sustainable and effective home care products has created impeccable opportunities for antimicrobial compounds. Also, with the huge application of antimicrobials in the construction industry, it has market opportunities to grow exponentially with the rise in real estate.
Regulations Adoption with Antimicrobials Implementation
The numerous benefits of antimicrobial agents can be recognized across various sectors, including health treatments. Despite several advantages, inappropriate usage of antimicrobial agents within healthcare facilities can decisively lead to the acquisition of nosocomial infections, drug toxicity, unwanted resistance build-up, etc. The World Health Organization (WHO) has framed effective regulations on different quantities and combinations for using antimicrobial agents in pharmaceuticals. Fixed doses of antimicrobial combinations can be banned if not approved by national or international guidelines. Stringent legislation has been implemented functionally, regulating the antimicrobials prescribed by qualified healthcare professionals.
Several antimicrobial awareness campaigns, such as World Antibiotic Awareness Week held in November each year by the World Health Organization (WHO) and similar relevant campaigns, are frequently organized to address the benefits of antimicrobials and their consumption in the prescribed form.
Scientifically validated clinical studies have been provided with specific regulations to justify the choice and level of antimicrobial agents to be incorporated in health-related applications. Between November 2021 and February 2022, the regulatory entities and experts from international organizations conducted semi-structured interviews with scientists’ regulators for India, Brazil, and South Africa to achieve and improve global and national perspectives on regulatory hurdles and evaluate innovation potential.
Antimicrobials Peptides Incorporated as Anticancer Agents Revolutionizing Healthcare Sector
Structurally described as small cationic or amphipathic molecules, antimicrobial peptides (AMPs) deliver an imperative fundamental defense against bacteria, viruses, and fungi. Several AMPs can target human cancer cells, specifically using their ability to bind the phospholipid phosphatidylserines (PS) that usually appear on the outer leaflet of plasma membranes. Recognized as a significant novel anticancer treatment, AMPs deliver a potential source of effective therapeutic agents and a primary defense against a broad spectrum of pathogens and harmful viruses.
According to the National Center for Health Statistics, the United States diagnosed approximately 1,918,030 cancer cases in 2022, where cancer rate in men was higher with 983,160 cases. Data published by Iqvia reported that the investment in 2022 on global cancer medicines was USD 196 billion, estimated to rise exponentially. The enormous potential for drug innovation in cancer treatment has incredibly generated huge opportunities for antimicrobial peptides globally.
Impact of COVID-19
The outbreak of COVID-19 had an unprecedented impact where the whole of mankind was vulnerable to the infectious disease. Due to the unavailability of significant antibiotics, antimicrobial resistance has successively threatened the entire healthcare system in treating untreatable bacterial infections. Some conventional practices, such as empirical antimicrobial prescription and excessive consumption of antimicrobial hygiene products, negatively impacted the prevalence of antimicrobial resistance. The pandemic significantly accentuated a bridge in sustainable funding across R&Ds of antimicrobial medicines and vaccine innovations. To address such challenges WHO and its partner Drugs for Neglected Diseases initiative (DNDi) progressively built the Global Antibiotic R&D Partnership (GARDP) to develop innovative and novel treatments. During the COVID-19 pandemic, the global market for antimicrobials was growing effectively which encouraged more companies to tackle the conflict of antimicrobial resistance.
The invasion of Russia on Ukraine has led to economic as well as physical devastation that has impacted various sectors leading to instability in sequential investment. In March 2019, the Government of Ukraine has approved the National Action Plan to combat antimicrobial resistance protecting unjustified usage of antimicrobial compounds in applications like livestock, poultry, medicine, crop development, etc. The aggression of Russia has severely impacted Ukraine’s healthcare system leading to increase of numerous bacterial infections among the injured soldiers. The medical aid from Western countries has stabilized the prevailing condition to a certain extent where such countries are regularly putting efforts to combat the war impact on the livelihood of Ukraine.
Global Antimicrobials Market: Report Scope
“Antimicrobials Market Assessment, Opportunities and Forecast, 2016-2030F”, is a comprehensive report by Markets and data, providing in-depth analysis and qualitative & quantitative assessment of the current state of the Antimicrobials Market, industry dynamics, and challenges. The report includes market size, segmental shares, growth trends, COVID-19 and Russia-Ukraine war impact, opportunities, and forecast between 2023 and 2030. Additionally, the report profiles the leading players in the industry mentioning their respective market share, business model, competitive intelligence, etc.
|
Report Attribute |
Details |
|
Base Year of the Analysis |
2022 |
|
Historical Period |
2016-2021 |
|
Forecast Period |
2023-2030 |
|
Projected Growth Rate |
CAGR of 4.7% between 2023 and 2030 |
|
Revenue Forecast in 2030 |
USD 60.4 billion |
|
Units |
Revenue in USD billion |
|
Segments Covered |
Grade, Type, Application, End-user |
|
Regions Covered |
North America, Europe, South America, Asia-Pacific, Middle East and Africa |
|
Key Companies Profiled |
Iasis Molecular Science, EnBiotix Inc., Armata Pharmaceuticals, GlaxoSmithKline, Fresenius Kabi Global, Destiny Pharma, Phico Therapeutics, SaNOtize, BioVersys, Pylum Biosciences |
|
Customization Scope |
15% free report customization with purchase |
|
Pricing and Purchase Options |
Avail the customized purchase options to fulfil your precise research needs |
|
Delivery Format |
PDF and Excel through email (subject to the license purchased) |
In this report, global antimicrobials market has been segmented into the following categories:
1. By Grade
1.1.1.Food Grade
1.1.2.Pharma Grade
1.1.3.Industrial Grade
2. By Type
2.1.1.Organics
2.1.1.1. Triclosan
2.1.1.2. Quaternary Ammonium Compounds
2.1.1.3. Others
2.1.2.Inorganics
2.1.2.1. Copper
2.1.2.2. Silver
2.1.2.3. Zinc
2.1.2.4. Others
3. By Applications
3.1.1.Antiviral Protection
3.1.2.Food Packaging
3.1.3.Bacterial Growth Inhibition
3.1.4.Others
4. By End-user
4.1.1.Homecare Essentials
4.1.2.Agriculture
4.1.3.Cleaners & Detergents
4.1.4.Paper & Pulp
4.1.5.Inks & Adhesives
4.1.6.Pharmaceuticals
4.1.7.Personal Care
4.1.8.Others
5. By Region
5.1. North America
5.2. Europe
5.3. South America
5.4. Asia-Pacific
5.5. Middle East and Africa
Key Players Landscape and Outlook
To deal with the antimicrobial resistance (AMR) that poses a serious threat to the healthcare systems in an unprecedented way, data reported that, due to hospital infections, an annual financial loss of around USD 13.5 billion occurred in the United States and the European Union. Bioversys is progressively working on innovations to fight antimicrobial resistance. It has prominently developed a diverse antimicrobial agent pipeline that specifically focuses on pathogens targeting gram-positive, gram-negative, and tuberculosis bacteria. Bioversys, on January 2023, has significantly extended the series C round to reach an investment of USD 35.07 million for AMR action, making its first European-based investment.
Key Players Operating in Antimicrobials Market are:
· Iasis Molecular Science
· EnBiotix Inc.
· Armata Pharmaceuticals
· GlaxoSmithKline
· Fresenius Kabi Global
· Destiny Pharma
· Phico Therapeutics
· SaNOtize
· BioVersys
· Pylum Biosciences
Markets and Data’s reports answer the following questions:
· What is the current and future market size of the product/service in question globally or specific to different countries?
· How are the markets divided into different product/service segments and each segment's market size and growth?
· What is the market potential of different product segments and their investment case?
· How are the markets predicted to develop in the future and what factors will drive or inhibit growth?
· What is the business environment and regulatory landscape specific to the product/service?
If you can't find what you're searching for or have any custom requirements for global antimicrobials market, you may approach our team at info@marketsandata.com
Table of Contents
1. Research Methodology
2. Project Scope & Definitions
3. Impact of COVID-19 on the Global Antimicrobials Market
4. Impact of Russia-Ukraine War
5. Executive Summary
6. Voice of Customer
6.1. Market Awareness and Product Information
6.2. Brand Awareness and Loyalty
6.3. Factors Considered in Purchase Decision
6.3.1.Brand Name
6.3.2.Quality
6.3.3.Quantity
6.3.4.Price
6.3.5.Product Specification
6.3.6. Application Specification
6.3.7.Shelf-life
6.3.8. Availability of Product
6.4. Frequency of Purchase
6.5. Medium of Purchase
7. Global Antimicrobials Market Outlook, 2016-2030F
7.1. Market Size & Forecast
7.1.1.By Value
7.1.2.By Volume
7.2. By Grade
7.2.1.Food Grade
7.2.2.Pharma Grade
7.2.3.Industrial Grade
7.3. By Type
7.3.1.Organics
7.3.1.1. Triclosan
7.3.1.2. Quaternary Ammonium Compounds
7.3.1.3. Others
7.3.2.Inorganics
7.3.2.1. Copper
7.3.2.2. Silver
7.3.2.3. Zinc
7.3.2.4. Others
7.4. By Applications
7.4.1.Antiviral Protection
7.4.2.Food Packaging
7.4.3.Bacterial Growth Inhibition
7.4.4.Others
7.5. By End-user
7.5.1.Homecare Essentials
7.5.2.Agriculture
7.5.3.Cleaners & Detergents
7.5.4.Paper & Pulp
7.5.5.Inks & Adhesives
7.5.6.Pharmaceuticals
7.5.7.Personal Care
7.5.8.Others
7.6. By Region
7.6.1.North America
7.6.2.Europe
7.6.3.South America
7.6.4.Asia-Pacific
7.6.5.Middle East and Africa
7.7. By Company Market Share (%), 2022
8. Global Antimicrobials Market Outlook, By Region, 2016-2030F
8.1. North America*
8.1.1.Market Size & Forecast
8.1.1.1. By Value
8.1.1.2. By Volume
8.1.2.By Grade
8.1.2.1. Food Grade
8.1.2.2. Pharma Grade
8.1.2.3. Industrial Grade
8.1.3.By Type
8.1.3.1. Organics
8.1.3.1.1. Triclosan
8.1.3.1.2. Quaternary Ammonium Compounds
8.1.3.1.3. Others
8.1.3.2. Inorganics
8.1.3.2.1. Copper
8.1.3.2.2. Silver
8.1.3.2.3. Zinc
8.1.3.2.4. Others
8.1.4.By Applications
8.1.4.1. Antiviral Protection
8.1.4.2. Food Packaging
8.1.4.3. Bacterial Growth Inhibition
8.1.4.4. Others
8.1.5.By End-user
8.1.5.1. Homecare Essentials
8.1.5.2. Agriculture
8.1.5.3. Cleaners & Detergents
8.1.5.4. Paper & Pulp
8.1.5.5. Inks & Adhesives
8.1.5.6. Pharmaceuticals
8.1.5.7. Personal Care
8.1.5.8. Others
8.1.6.United States*
8.1.6.1. Market Size & Forecast
8.1.6.1.1. By Value
8.1.6.1.2. By Volume
8.1.6.2. By Grade
8.1.6.2.1. Food Grade
8.1.6.2.2. Pharma Grade
8.1.6.2.3. Industrial Grade
8.1.6.3. By Type
8.1.6.3.1. Organics
8.1.6.3.1.1. Triclosan
8.1.6.3.1.2. Quaternary Ammonium Compounds
8.1.6.3.1.3. Others
8.1.6.3.2. Inorganics
8.1.6.3.2.1. Copper
8.1.6.3.2.2. Silver
8.1.6.3.2.3. Zinc
8.1.6.3.2.4. Others
8.1.6.4. By Applications
8.1.6.4.1. Antiviral Protection
8.1.6.4.2. Food Packaging
8.1.6.4.3. Bacterial Growth Inhibition
8.1.6.4.4. Others
8.1.6.5. By End-user
8.1.6.5.1. Homecare Essentials
8.1.6.5.2. Agriculture
8.1.6.5.3. Cleaners & Detergents
8.1.6.5.4. Paper & Pulp
8.1.6.5.5. Inks & Adhesives
8.1.6.5.6. Pharmaceuticals
8.1.6.5.7. Personal Care
8.1.6.5.8. Others
8.1.7.Canada
8.1.8.Mexico
*All segments will be provided for all regions and countries covered
8.2. Europe
8.2.1.Germany
8.2.2.France
8.2.3.Italy
8.2.4.United Kingdom
8.2.5.Russia
8.2.6.Netherlands
8.2.7.Spain
8.2.8.Turkey
8.2.9.Poland
8.3. South America
8.3.1.Brazil
8.3.2.Argentina
8.4. Asia-Pacific
8.4.1.India
8.4.2.China
8.4.3.Japan
8.4.4.Australia
8.4.5.Vietnam
8.4.6.South Korea
8.4.7.Indonesia
8.4.8.Philippines
8.5. Middle East & Africa
8.5.1.Saudi Arabia
8.5.2.UAE
8.5.3.South Africa
9. Supply Side Analysis
9.1. Capacity, By Company
9.2. Production, By Company
9.3. Operating Efficiency, By Company
9.4. Key Plant Locations (Up to 25)
10. Market Mapping, 2022
10.1. By Grade
10.2. By Type
10.3. By Application
10.4. By End-user
10.5. By Region
11. Macro Environment and Industry Structure
11.1. Supply Demand Analysis
11.2. Import Export Analysis – Volume and Value
11.3. Supply/Value Chain Analysis
11.4. PESTEL Analysis
11.4.1. Political Factors
11.4.2. Economic System
11.4.3. Social Implications
11.4.4. Technological Advancements
11.4.5. Environmental Impacts
11.4.6. Legal Compliances and Regulatory Policies (Statutory Bodies Included)
11.5. Porter’s Five Forces Analysis
11.5.1. Supplier Power
11.5.2. Buyer Power
11.5.3. Substitution Threat
11.5.4. Threat from New Entrant
11.5.5. Competitive Rivalry
12. Market Dynamics
12.1. Growth Drivers
12.2. Growth Inhibitors (Challenges, Restraints)
13. Key Players Landscape
13.1. Competition Matrix of Top Five Market Leaders
13.2. Market Revenue Analysis of Top Five Market Leaders (in %, 2022)
13.3. Mergers and Acquisitions/Joint Ventures (If Applicable)
13.4. SWOT Analysis (For Five Market Players)
13.5. Patent Analysis (If Applicable)
14. Pricing Analysis
15. Case Studies
16. Key Players Outlook
16.1. Iasis Molecular Science
16.1.1. Company Details
16.1.2. Key Management Personnel
16.1.3. Products & Services
16.1.4. Financials (As reported)
16.1.5. Key Market Focus & Geographical Presence
16.1.6. Recent Developments
16.2. EnBiotix Inc.
16.3. Armata Pharmaceuticals
16.4. GlaxoSmithKline
16.5. Fresenius Kabi Global
16.6. Destiny Pharma
16.7. Phico Therapeutics
16.8. SaNOtize
16.9. BioVersys
16.10. Pylum Biosciences
*Companies mentioned above DO NOT hold any order as per market share and can be changed as per information available during research work
17. Strategic Recommendations
18. About Us & Disclaimer
List of Figures: Global Antimicrobials Market
Figure 1. Global Antimicrobials Market, By Value, In USD Billion, 2016-2030F
Figure 2. Global Antimicrobials Market, By Volume, In Kilotons, 2016-2030F
Figure 3. Global Antimicrobials Market Share, By Grade, In USD Billion, 2016-2030F
Figure 4. Global Antimicrobials Market Share, By Type, In USD Billion, 2016-2030F
Figure 5. Global Antimicrobials Market Share, By Applications, In USD Billion, 2016-2030F
Figure 6. Global Antimicrobials Market Share, By End-user Industry, In USD Billion, 2016-2030F
Figure 7. Global Antimicrobials Market Share, By Region, In USD Billion, 2016-2030F
Figure 8. North America Antimicrobials Market, By Value, In USD Billion, 2016-2030F
Figure 9. North America Antimicrobials Market, By Volume, In Kilotons, 2016-2030F
Figure 10. North America Antimicrobials Market Share, By Grade, In USD Billion, 2016-2030F
Figure 11. North America Antimicrobials Market Share, By Type, In USD Billion, 2016-2030F
Figure 12. North America Antimicrobials Market Share, By Applications, In USD Billion, 2016-2030F
Figure 13. North America Antimicrobials Market Share, By End-user Industry, In USD Billion, 2016-2030F
Figure 14. North America Antimicrobials Market Share, By Country, In USD Billion, 2016-2030F
Figure 15. United States Antimicrobials Market, By Value, In USD Billion, 2016-2030F
Figure 16. United States Antimicrobials Market, By Volume, In Kilotons, 2016-2030F
Figure 17. United States Antimicrobials Market Share, By Grade, In USD Billion, 2016-2030F
Figure 18. United States Antimicrobials Market Share, By Type, In USD Billion, 2016-2030F
Figure 19. United States Antimicrobials Market Share, By Applications, In USD Billion, 2016-2030F
Figure 20. United States Antimicrobials Market Share, By End-user Industry, In USD Billion, 2016-2030F
Figure 21. Canada Antimicrobials Market, By Value, In USD Billion, 2016-2030F
Figure 22. Canada Antimicrobials Market, By Volume, In Kilotons, 2016-2030F
Figure 23. Canada Antimicrobials Market Share, By Grade, In USD Billion, 2016-2030F
Figure 24. Canada Antimicrobials Market Share, By Type, In USD Billion, 2016-2030F
Figure 25. Canada Antimicrobials Market Share, By Applications, In USD Billion, 2016-2030F
Figure 26. Canada Antimicrobials Market Share, By End-user Industry, In USD Billion, 2016-2030F
Figure 27. Mexico Antimicrobials Market, By Value, In USD Billion, 2016-2030F
Figure 28. Mexico Antimicrobials Market, By Volume, In Kilotons, 2016-2030F
Figure 29. Mexico Antimicrobials Market Share, By Grade, In USD Billion, 2016-2030F
Figure 30. Mexico Antimicrobials Market Share, By Type, In USD Billion, 2016-2030F
Figure 31. Mexico Antimicrobials Market Share, By Applications, In USD Billion, 2016-2030F
Figure 32. Mexico Antimicrobials Market Share, By End-user Industry, In USD Billion, 2016-2030F
Figure 33. Europe Antimicrobials Market, By Value, In USD Billion, 2016-2030F
Figure 34. Europe Antimicrobials Market, By Volume, In Kilotons, 2016-2030F
Figure 35. Europe Antimicrobials Market Share, By Grade, In USD Billion, 2016-2030F
Figure 36. Europe Antimicrobials Market Share, By Type, In USD Billion, 2016-2030F
Figure 37. Europe Antimicrobials Market Share, By Applications, In USD Billion, 2016-2030F
Figure 38. Europe Antimicrobials Market Share, By End-user Industry, In USD Billion, 2016-2030F
Figure 39. Europe Antimicrobials Market Share, By Country, In USD Billion, 2016-2030F
Figure 40. Germany Antimicrobials Market, By Value, In USD Billion, 2016-2030F
Figure 41. Germany Antimicrobials Market, By Volume, In Kilotons, 2016-2030F
Figure 42. Germany Antimicrobials Market Share, By Grade, In USD Billion, 2016-2030F
Figure 43. Germany Antimicrobials Market Share, By Type, In USD Billion, 2016-2030F
Figure 44. Germany Antimicrobials Market Share, By Applications, In USD Billion, 2016-2030F
Figure 45. Germany Antimicrobials Market Share, By End-user Industry, In USD Billion, 2016-2030F
Figure 46. France Antimicrobials Market, By Value, In USD Billion, 2016-2030F
Figure 47. France Antimicrobials Market, By Volume, In Kilotons, 2016-2030F
Figure 48. France Antimicrobials Market Share, By Grade, In USD Billion, 2016-2030F
Figure 49. France Antimicrobials Market Share, By Type, In USD Billion, 2016-2030F
Figure 50. France Antimicrobials Market Share, By Applications, In USD Billion, 2016-2030F
Figure 51. France Antimicrobials Market Share, By End-user Industry, In USD Billion, 2016-2030F
Figure 52. Italy Antimicrobials Market, By Value, In USD Billion, 2016-2030F
Figure 53. Italy Antimicrobials Market, By Volume, In Kilotons, 2016-2030F
Figure 54. Italy Antimicrobials Market Share, By Grade, In USD Billion, 2016-2030F
Figure 55. Italy Antimicrobials Market Share, By Type, In USD Billion, 2016-2030F
Figure 56. Italy Antimicrobials Market Share, By Applications, In USD Billion, 2016-2030F
Figure 57. Italy Antimicrobials Market Share, By End-user Industry, In USD Billion, 2016-2030F
Figure 58. United Kingdom Antimicrobials Market, By Value, In USD Billion, 2016-2030F
Figure 59. United Kingdom Antimicrobials Market, By Volume, In Kilotons, 2016-2030F
Figure 60. United Kingdom Antimicrobials Market Share, By Grade, In USD Billion, 2016-2030F
Figure 61. United Kingdom Antimicrobials Market Share, By Type, In USD Billion, 2016-2030F
Figure 62. United Kingdom Antimicrobials Market Share, By Applications, In USD Billion, 2016-2030F
Figure 63. United Kingdom Antimicrobials Market Share, By End-user Industry, In USD Billion, 2016-2030F
Figure 64. Russia Antimicrobials Market, By Value, In USD Billion, 2016-2030F
Figure 65. Russia Antimicrobials Market, By Volume, In Kilotons, 2016-2030F
Figure 66. Russia Antimicrobials Market Share, By Grade, In USD Billion, 2016-2030F
Figure 67. Russia Antimicrobials Market Share, By Type, In USD Billion, 2016-2030F
Figure 68. Russia Antimicrobials Market Share, By Applications, In USD Billion, 2016-2030F
Figure 69. Russia Antimicrobials Market Share, By End-user Industry, In USD Billion, 2016-2030F
Figure 70. Netherlands Antimicrobials Market, By Value, In USD Billion, 2016-2030F
Figure 71. Netherlands Antimicrobials Market, By Volume, In Kilotons, 2016-2030F
Figure 72. Netherlands Antimicrobials Market Share, By Grade, In USD Billion, 2016-2030F
Figure 73. Netherlands Antimicrobials Market Share, By Type, In USD Billion, 2016-2030F
Figure 74. Netherlands Antimicrobials Market Share, By Applications, In USD Billion, 2016-2030F
Figure 75. Netherlands Antimicrobials Market Share, By End-user Industry, In USD Billion, 2016-2030F
Figure 76. Spain Antimicrobials Market, By Value, In USD Billion, 2016-2030F
Figure 77. Spain Antimicrobials Market, By Volume, In Kilotons, 2016-2030F
Figure 78. Spain Antimicrobials Market Share, By Grade, In USD Billion, 2016-2030F
Figure 79. Spain Antimicrobials Market Share, By Type, In USD Billion, 2016-2030F
Figure 80. Spain Antimicrobials Market Share, By Applications, In USD Billion, 2016-2030F
Figure 81. Spain Antimicrobials Market Share, By End-user Industry, In USD Billion, 2016-2030F
Figure 82. Turkey Antimicrobials Market, By Value, In USD Billion, 2016-2030F
Figure 83. Turkey Antimicrobials Market, By Volume, In Kilotons, 2016-2030F
Figure 84. Turkey Antimicrobials Market Share, By Grade, In USD Billion, 2016-2030F
Figure 85. Turkey Antimicrobials Market Share, By Type, In USD Billion, 2016-2030F
Figure 86. Turkey Antimicrobials Market Share, By Applications, In USD Billion, 2016-2030F
Figure 87. Turkey Antimicrobials Market Share, By End-user Industry, In USD Billion, 2016-2030F
Figure 88. Poland Antimicrobials Market, By Value, In USD Billion, 2016-2030F
Figure 89. Poland Antimicrobials Market, By Volume, In Kilotons, 2016-2030F
Figure 90. Poland Antimicrobials Market Share, By Grade, In USD Billion, 2016-2030F
Figure 91. Poland Antimicrobials Market Share, By Type, In USD Billion, 2016-2030F
Figure 92. Poland Antimicrobials Market Share, By Applications, In USD Billion, 2016-2030F
Figure 93. Poland Antimicrobials Market Share, By End-user Industry, In USD Billion, 2016-2030F
Figure 94. South America Antimicrobials Market, By Value, In USD Billion, 2016-2030F
Figure 95. South America Antimicrobials Market, By Volume, In Kilotons, 2016-2030F
Figure 96. South America Antimicrobials Market Share, By Grade, In USD Billion, 2016-2030F
Figure 97. South America Antimicrobials Market Share, By Type, In USD Billion, 2016-2030F
Figure 98. South America Antimicrobials Market Share, By Applications, In USD Billion, 2016-2030F
Figure 99. South America Antimicrobials Market Share, By End-user Industry, In USD Billion, 2016-2030F
Figure 100. South America Antimicrobials Market Share, By Country, In USD Billion, 2016-2030F
Figure 101. Brazil Antimicrobials Market, By Value, In USD Billion, 2016-2030F
Figure 102. Brazil Antimicrobials Market, By Volume, In Kilotons, 2016-2030F
Figure 103. Brazil Antimicrobials Market Share, By Grade, In USD Billion, 2016-2030F
Figure 104. Brazil Antimicrobials Market Share, By Type, In USD Billion, 2016-2030F
Figure 105. Brazil Antimicrobials Market Share, By Applications, In USD Billion, 2016-2030F
Figure 106. Brazil Antimicrobials Market Share, By End-user Industry, In USD Billion, 2016-2030F
Figure 107. Argentina Antimicrobials Market, By Value, In USD Billion, 2016-2030F
Figure 108. Argentina Antimicrobials Market, By Volume, In Kilotons, 2016-2030F
Figure 109. Argentina Antimicrobials Market Share, By Grade, In USD Billion, 2016-2030F
Figure 110. Argentina Antimicrobials Market Share, By Type, In USD Billion, 2016-2030F
Figure 111. Argentina Antimicrobials Market Share, By Applications, In USD Billion, 2016-2030F
Figure 112. Argentina Antimicrobials Market Share, By End-user Industry, In USD Billion, 2016-2030F
Figure 113. Asia-Pacific Antimicrobials Market, By Value, In USD Billion, 2016-2030F
Figure 114. Asia-Pacific Antimicrobials Market, By Volume, In Kilotons, 2016-2030F
Figure 115. Asia-Pacific Antimicrobials Market Share, By Grade, In USD Billion, 2016-2030F
Figure 116. Asia-Pacific Antimicrobials Market Share, By Type, In USD Billion, 2016-2030F
Figure 117. Asia-Pacific Antimicrobials Market Share, By Applications, In USD Billion, 2016-2030F
Figure 118. Asia- Pacific Cream Market Share, By End-user Industry, In USD Billion, 2016-2030F
Figure 119. Asia-Pacific Antimicrobials Market Share, By Country, In USD Billion, 2016-2030F
Figure 120. India Antimicrobials Market, By Value, In USD Billion, 2016-2030F
Figure 121. India Antimicrobials Market, By Volume, In Kilotons, 2016-2030F
Figure 122. India Antimicrobials Market Share, By Grade, In USD Billion, 2016-2030F
Figure 123. India Antimicrobials Market Share, By Type, In USD Billion, 2016-2030F
Figure 124. India Antimicrobials Market Share, By Applications, In USD Billion, 2016-2030F
Figure 125. India Antimicrobials Market Share, By End-user Industry, In USD Billion, 2016-2030F
Figure 126. China Antimicrobials Market, By Value, In USD Billion, 2016-2030F
Figure 127. China Antimicrobials Market, By Volume, In Kilotons, 2016-2030F
Figure 128. China Antimicrobials Market Share, By Grade, In USD Billion, 2016-2030F
Figure 129. China Antimicrobials Market Share, By Type, In USD Billion, 2016-2030F
Figure 130. China Antimicrobials Market Share, By Applications, In USD Billion, 2016-2030F
Figure 131. China Antimicrobials Market Share, By End-user Industry, In USD Billion, 2016-2030F
Figure 132. Japan Antimicrobials Market, By Value, In USD Billion, 2016-2030F
Figure 133. Japan Antimicrobials Market, By Volume, In Kilotons, 2016-2030F
Figure 134. Japan Antimicrobials Market Share, By Grade, In USD Billion, 2016-2030F
Figure 135. Japan Antimicrobials Market Share, By Type, In USD Billion, 2016-2030F
Figure 136. Japan Antimicrobials Market Share, By Applications, In USD Billion, 2016-2030F
Figure 137. Japan Antimicrobials Market Share, By End-user Industry, In USD Billion, 2016-2030F
Figure 138. Australia Antimicrobials Market, By Value, In USD Billion, 2016-2030F
Figure 139. Australia Antimicrobials Market, By Volume, In Kilotons, 2016-2030F
Figure 140. Australia Antimicrobials Market Share, By Grade, In USD Billion, 2016-2030F
Figure 141. Australia Antimicrobials Market Share, By Type, In USD Billion, 2016-2030F
Figure 142. Australia Antimicrobials Market Share, By Applications, In USD Billion, 2016-2030F
Figure 143. Australia Antimicrobials Market Share, By End-user Industry, In USD Billion, 2016-2030F
Figure 144. Vietnam Antimicrobials Market, By Value, In USD Billion, 2016-2030F
Figure 145. Vietnam Antimicrobials Market, By Volume, In Kilotons, 2016-2030F
Figure 146. Vietnam Antimicrobials Market Share, By Grade, In USD Billion, 2016-2030F
Figure 147. Vietnam Antimicrobials Market Share, By Type, In USD Billion, 2016-2030F
Figure 148. Vietnam Antimicrobials Market Share, By Applications, In USD Billion, 2016-2030F
Figure 149. Vietnam Antimicrobials Market Share, By End-user Industry, In USD Billion, 2016-2030F
Figure 150. South Korea Antimicrobials Market, By Value, In USD Billion, 2016-2030F
Figure 151. South Korea Antimicrobials Market, By Volume, In Kilotons, 2016-2030F
Figure 152. South Korea Antimicrobials Market Share, By Grade, In USD Billion, 2016-2030F
Figure 153. South Korea Antimicrobials Market Share, By Type, In USD Billion, 2016-2030F
Figure 154. South Korea Antimicrobials Market Share, By Applications, In USD Billion, 2016-2030F
Figure 155. South Korea Antimicrobials Market Share, By End-user Industry, In USD Billion, 2016-2030F
Figure 156. Indonesia Antimicrobials Market, By Value, In USD Billion, 2016-2030F
Figure 157. Indonesia Antimicrobials Market, By Volume, In Kilotons, 2016-2030F
Figure 158. Indonesia Antimicrobials Market Share, By Grade, In USD Billion, 2016-2030F
Figure 159. Indonesia Antimicrobials Market Share, By Type, In USD Billion, 2016-2030F
Figure 160. Indonesia Antimicrobials Market Share, By Applications, In USD Billion, 2016-2030F
Figure 161. Indonesia Antimicrobials Market Share, By End-user Industry, In USD Billion, 2016-2030F
Figure 162. Philippines Antimicrobials Market, By Value, In USD Billion, 2016-2030F
Figure 163. Philippines Antimicrobials Market, By Volume, In Kilotons, 2016-2030F
Figure 164. Philippines Antimicrobials Market Share, By Grade, In USD Billion, 2016-2030F
Figure 165. Philippines Antimicrobials Market Share, By Type, In USD Billion, 2016-2030F
Figure 166. Philippines Antimicrobials Market Share, By Applications, In USD Billion, 2016-2030F
Figure 167. Philippines Antimicrobials Market Share, By End-user Industry, In USD Billion, 2016-2030F
Figure 168. Middle East & Africa Antimicrobials Market, By Value, In USD Billion, 2016-2030F
Figure 169. Middle East & Africa Antimicrobials Market, By Volume, In Kilotons, 2016-2030F
Figure 170. Middle East & Africa Antimicrobials Market Share, By Grade, In USD Billion, 2016-2030F
Figure 171. Middle East & Africa Antimicrobials Market Share, By Type, In USD Billion, 2016-2030F
Figure 172. Middle East & Africa Antimicrobials Market Share, By Applications, In USD Billion, 2016-2030F
Figure 173. Middle East & Africa Antimicrobials Market Share, By End-user Industry, In USD Billion, 2016-2030F
Figure 174. Middle East & Africa Antimicrobials Market Share, By Country, In USD Billion, 2016-2030F
Figure 175. Saudi Arabia Antimicrobials Market, By Value, In USD Billion, 2016-2030F
Figure 176. Saudi Arabia Antimicrobials Market, By Volume, In Kilotons, 2016-2030F
Figure 177. Saudi Arabia Antimicrobials Market Share, By Grade, In USD Billion, 2016-2030F
Figure 178. Saudi Arabia Antimicrobials Market Share, By Type, In USD Billion, 2016-2030F
Figure 179. Saudi Arabia Antimicrobials Market Share, By Applications, In USD Billion, 2016-2030F
Figure 180. Saudi Arabia Antimicrobials Market Share, By End-user Industry, In USD Billion, 2016-2030F
Figure 181. UAE Antimicrobials Market, By Value, In USD Billion, 2016-2030F
Figure 182. UAE Antimicrobials Market, By Volume, In Kilotons, 2016-2030F
Figure 183. UAE Antimicrobials Market Share, By Grade, In USD Billion, 2016-2030F
Figure 184. UAE Antimicrobials Market Share, By Type, In USD Billion, 2016-2030F
Figure 185. UAE Antimicrobials Market Share, By Applications, In USD Billion, 2016-2030F
Figure 186. UAE Antimicrobials Market Share, By End-user Industry, In USD Billion, 2016-2030F
Figure 187. South Africa Antimicrobials Market, By Value, In USD Billion, 2016-2030F
Figure 188. South Africa Antimicrobials Market, By Volume, In Kilotons, 2016-2030F
Figure 189. South Africa Antimicrobials Market Share, By Grade, In USD Billion, 2016-2030F
Figure 190. South Africa Antimicrobials Market Share, By Type, In USD Billion, 2016-2030F
Figure 191. South Africa Antimicrobials Market Share, By Applications, In USD Billion, 2016-2030F
Figure 192. South Africa Antimicrobials Market Share, By End-user Industry, In USD Billion, 2016-2030F
Figure 193. By Grade Map-Market Size (USD Billion) & Growth Rate (%), 2022
Figure 194. By Type Map-Market Size (USD Billion) & Growth Rate (%), 2022
Figure 195. By Applications Map-Market Size (USD Billion) & Growth Rate (%), 2022
Figure 196. By End-user Industry Map-Market Size (USD Billion) & Growth Rate (%), 2022
Figure 197. By Region Map-Market Size (USD Billion) & Growth Rate (%), 2022
List of Tables: Global Antimicrobials Market
Table 1. Pricing Analysis of Products from Key Players
Table 2. Competition Matrix of Top 5 Market Leaders
Table 3. Mergers & Acquisitions/ Joint Ventures (If Applicable)
Table 4. About Us - Regions and Countries Where We Have Executed Client Projects
Frequently Asked Questions
What are the regions covered in the final report of the global antimicrobials market?
Who are the key players operating in the global antimicrobials market?
What are the major drivers influencing the growth of the global antimicrobials market?
What is the global antimicrobials market's market size and growth rate?
See Related Reports
Global Coffee Market Assessment, Opportunities and Forecast, 2017-2031F
Global coffee market is expected to experience growth due to consumers’ increasing preference for organic and premium coffee that offers freshness, superior quality of beans and roasts, and unique flavor profile. Additionally, the product innovation,....Read More
Published on
July 2024
4,500
Global Home Theater System Market Assessment, Opportunities and Forecast, 2017-2031F
Global home theater system market is expected to experience growth due to technological advancements, increasing disposable incomes, rising demand for high-definition content, integration with smart home systems, and the surge in streaming services p....Read More
Published on
July 2024
4,500
Global Baby Food Market Assessment, Opportunities and Forecast, 2017-2031F
Global baby food market is expected to experience growth due to factors such as consumers’ increasing awareness of the nutrients which are essential for babies development and introduction of wide variety of baby foods in the market from milk powders....Read More
Published on
July 2024
4,500
Global Isoflavones Market Assessment, Opportunities and Forecast, 2017-2031F
Global isoflavones market is expected to experience growth due to increasing consumer health awareness, rising demand for functional foods and nutraceuticals, advancements in extraction technologies, and expanding applications in cosmetics, pharmaceu....Read More
Published on
July 2024
4,500
Purchase Options
USD ($)
i
3,000
i
4,500
i
5,700
i
8,200
Tired of Searching?
Looking for Customization?
Some other doubt?
Need insights from a cohort?
REACH US
